Respiratory Strategic Vision

When it comes to inhalation APIs, precision, consistency, and regulatory confidence are not optional—they are essential. Pharmaceutical companies developing inhaled therapies face the constant challenge of ensuring that every particle, every formulation, and every process step meets the highest standards of performance and safety. The complexity of delivering active ingredients directly to the lungs requires deep scientific understanding and specialized manufacturing expertise.

At Inke, we empower our partners to overcome these challenges through a fully integrated approach to the development and production of inhalation-grade active pharmaceutical ingredients (APIs). Our focus lies in supporting innovators and generic manufacturers who need reliable, high-quality APIs specifically optimized for respiratory drug delivery.

As a trusted partner to major generic and branded companies, Inke has solidified its position as a key supplier in the global pharmaceutical landscape. Headquartered in Barcelona, Spain, our reach extends far beyond borders, with a continuous international expansion spanning over two decades through more than 35 countries. From Europe to the United States, Japan, Korea, and China, Inke delivers cutting-edge APIs to every corner of the globe, advancing respiratory care and improving patient outcomes on a global scale.

We believe innovation is what separates good inhalation APIs from great ones. At Inke, we’ve invested heavily in R&D to push the boundaries of inhalation drug development. This continuous innovation also feeds into how we design inhaled drug formulation, helping our clients reach target delivery profiles with reduced variability.

Our process engineering is built around critical in process controls, cleaning validation, and environmental controls (ISO-7 at final stages). We take pride in our ability to work with contained equipment for hazardous chemistry and advanced particle engineering. To see how our innovation arm contributes, visit our innovation page.

We understand the pain points of companies developing inhaled therapies: unpredictable particle behaviour, batch inconsistency, regulatory delays, and difficulty in scaling. With Inke, you get a partner who addresses all those: we deliver respiratory APIs with tight specifications, reproducible performance, and strong regulatory backing. We take pride in being proactive, not reactive—anticipating challenges in inhaled drug formulation and solving them early.

Moreover, we don’t just make APIs—we aim to be part of your success story. From the early R&D stage through process validation, manufacturing, and market entry, we offer comprehensive support. We stand among the top in Europe not only for the number of patents we hold but for our commitment to scientific excellence, strong active ingredients for use in respiratory inhalation, and customer collaboration. To understand where we come from and our track record, you can explore our history page.